Cost Splitting AgreementCost Splitting Agreement • April 21st, 2017 • ObsEva SA • Pharmaceutical preparations
Contract Type FiledApril 21st, 2017 Company IndustryThis Cost Split Agreement (the “Agreement”) made on February 6th, 2017 (the “Effective Date”) by and between Kissei Pharmaceutical Co., Ltd., having its registered office at 19-48, Yoshino, Matsumoto-City, Nagano-Prefecture, Japan (“Kissei”) and ObsEva SA, having its principal place of business at Chemin des Aulx, 12, 1228 Plan-les-Ouates, Switzerland (“ObsEva”).